Chemtura (CHMT -10.5%) shares plunge after the maker of specialty chemicals is downgraded at Oppenheimer, which says Q4 results showed CHMT may be approaching the limits to further margin improvement without a healthier economy. Also, legacy overhead costs from its antioxidants sale will hamper margins, and 2013 capex needs are higher than expected.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs